Molgramostim biosimilar - Reliance GeneMedix
Alternative Names: GM-CSF - Reliance GeneMedix; NeustimLatest Information Update: 17 Jun 2015
At a glance
- Originator GeneMedix Plc
- Developer Reliance GeneMedix
- Class Antibacterials; Antibronchitics; Antifibrotics; Antineoplastics; Chemoprotectants; Immunotherapies; Recombinant proteins
- Mechanism of Action Granulocyte macrophage colony stimulating factor agonists; Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Neutropenia